Abstract
Background
The objective of this study was to estimate the economic burden attributable to laboratory-confirmed Lyme disease (LD) in Ontario, Canada and assess health outcomes associated with LD.
Method
We conducted a cohort study using laboratory-confirmed LD cases accrued between 2006 and 2018. The exposed cohort was matched 1:3 to the unexposed cohort using a combination of hard and propensity score matching. We used phase-of-care costing methods to calculate attributable costs for four phases of illness: pre-diagnosis, acute care, post-acute care, and continuing care in 2018 Canadian dollars. We used ICD-10-CA and OHIP billing codes to identify emergency department visits, physician billings and hospitalizations related to LD sequelae to assess health outcomes.
Results
A total of 2,808 cases were identified with a mean age of 46.5 (20.7) years and 44% female. Within 30-days, 404 (14.3%) cases required an ED visit and 63 (2.4%) cases required hospitalization. The mean (95% CI) total costs for LD cases in pre-diagnosis, acute, and post-acute care phases were $209 ($181, 238), $1,084 ($956, $1,212), and $1,714 ($1,499, $1,927), respectively. The highest mean attributable 10-day cost was $275 ($231, $319) during acute care. At 1-year post-infection, LD increased the relative risk of nerve palsies by 62 (20, 197), and polyneuropathy by 24 (3.0, 190). LD resulted in 16 Lyme meningitis events vs. 0 events in the unexposed.
Conclusion
Individuals with laboratory-confirmed LD have increased healthcare resource use pre-diagnosis and up to six months post-diagnosis, and were more likely to seek healthcare services related to LD sequelae.
Funder
Canadian Institutes of Health Research
Canada Research Chairs
Publisher
Public Library of Science (PLoS)
Reference29 articles.
1. Lyme Disease: Knowing Good Evidence to Help Inform Practice;PG Auwaerter;Infect Dis Clin North Am,2015
2. Government of Canada. Surveillance of Lyme disease [Internet]. 2021 [cited 25 Sep 2021]. Available: https://www.canada.ca/en/public-health/services/diseases/lyme-disease/surveillance-lyme-disease.html
3. Government of Canada. Lyme disease 2016 case definition [Internet]. 2020 [cited 5 Jan 2021]. Available: https://www.canada.ca/en/public-health/services/diseases/lyme-disease/surveillance-lyme-disease/case-definition.html
4. Health Care Costs, Utilization and Patterns of Care following Lyme Disease;ER Adrion;PLoS One,2015
5. The economic burden of lyme disease and the cost-effectiveness of lyme disease interventions: A scoping review;S Mac;PLoS One,2019